ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
26K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
26K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vrs37
|
279 |
94K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
279
|
94K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
47K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
47K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
153
|
47K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
0 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
640
|
228K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
2 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
640
|
228K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
228K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
228K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
228K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
228K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
228K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
228K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
163 |
56K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
163
|
56K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
163 |
56K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
163
|
56K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Interim Analyses of Clinical Trials
|
|
vrs37
|
185 |
53K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
185
|
53K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
58
|
16K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
vrs37
|
153 |
38K |
4 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
153
|
38K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
vrs37
|
153 |
38K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
153
|
38K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
vrs37
|
153 |
38K |
5 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
153
|
38K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
56K |
2 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
176
|
56K
|
2
|
|